Sterling Capital Management
ORIC icon

Sterling Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Sterling Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.7K Buy
1,756
+630
+56% +$7.84K ﹤0.01% 2112
2026
Q2 		$12.2K Sell
1,126
-575
-34% -$5.21K ﹤0.01% 2115
2026
Q1 		$21.6K Sell
1,701
-1,137
-40% -$12.9K ﹤0.01% 1997
2025
Q4 		$23.2K Sell
2,838
-71
-2% -$817 ﹤0.01% 2145
2025
Q3 		$34.9K Buy
2,909
+2,008
+223% +$21.1K ﹤0.01% 1898
2025
Q2 		$9.14K Buy
901
+67
+8% +$450 ﹤0.01% 2183
2025
Q1 		$4.65K Sell
834
-702
-46% -$6.14K ﹤0.01% 2198
2024
Q4 		$12.4K Buy
1,536
+1,354
+744% +$12.4K ﹤0.01% 2066
2024
Q3 		$1.87K Buy
+182
New +$1.8K ﹤0.01% 2217

Other funds holding ORIC

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Sterling Capital Management's ORIC Position: Q3 2026 in Review

Sterling Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 56% in Q3 2026, buying an estimated $7.84K and bringing the position to 1,756 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Sterling Capital Management first reported a position in ORIC in Q3 2024 and has held it in 9 quarters since. The position peaked at $34.9K in Q3 2025. 17 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Sterling Capital Management held 1,756 shares of Oric Pharmaceuticals worth $23.7K as of Q3 2026.
  • Sterling Capital Management bought 630 Oric Pharmaceuticals shares in Q3 2026, an estimated $7.84K.
  • Oric Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2112 holding.
  • Sterling Capital Management first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Oric Pharmaceuticals position peaked at $34.9K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.